Filios Alta Medicina sa de cv
Monterrey, Nuevo León 64570
0 studies enrolling now · 2 studies all time
What they study most
Advanced or Metastatic Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Studies at this site
- Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed
- A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment — Running, not enrolling